Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

Clicks: 473
ID: 121287
1983
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #32 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus. Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days. Seventeen infants w …
Reference Key
cb1983theaerosolized Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hall CB;McBride JT;Walsh EE;Bell DM;Gala CL;Hildreth S;Ten Eyck LG;Hall WJ;;
Journal The New England journal of medicine
Year 1983
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.